0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Depressant Market Insights, Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-37Q6475
Home | Market Reports | Health | Pharmacy | Drugs & Medications
Global Anti Depressant Market Insights Forecast to 2028

Global Anti-Depressant Market Insights, Forecast to 2028

Code: QYRE-Auto-37Q6475
Report
January 2022
111 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
Market Analysis and Insights: Global Anti-Depressant Market

Due to the COVID-19 pandemic, the global Anti-Depressant market size is estimated to be worth US$ 14890 million in 2022 and is forecast to a readjusted size of US$ 18090 million by 2028 with a CAGR of 3.3% during the review period.

Fully considering the economic change by this health crisis, Tricyclic Antidepressants accounting for % of the Anti-Depressant global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Major Depressive Disorder segment is altered to an % CAGR throughout this forecast period.
China Anti-Depressant market size is valued at US$ million in 2021, while the US and Europe Anti-Depressant are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Anti-Depressant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Anti-Depressant include Alkermes, Allergan, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Pfizer and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anti-Depressant Scope and Segment
Anti-Depressant market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anti-Depressant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist
Reuptake Inhibitors
Others

Segment by Application

Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others

BY COMPANY

Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Anti-Depressant Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Depressant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tricyclic Antidepressants
1.2.3 Selective Serotonin Reuptake Inhibitors
1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Serotonin Antagonist
1.2.7 Reuptake Inhibitors
1.2.8 Others
1.3 Market by Application
1.3.1 Global Anti-Depressant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Major Depressive Disorder
1.3.3 Obsessive-Compulsive Disorder
1.3.4 Generalized Anxiety Disorder
1.3.5 Panic Disorder
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Depressant Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Depressant Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Depressant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Depressant Sales by Region
2.4.1 Global Anti-Depressant Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Depressant by Region (2023-2028)
2.5 Global Anti-Depressant Revenue by Region
2.5.1 Global Anti-Depressant Revenue by Region (2017-2022)
2.5.2 Global Anti-Depressant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Depressant Sales by Manufacturers
3.1.1 Global Top Anti-Depressant Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Depressant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Depressant in 2021
3.2 Global Anti-Depressant Revenue by Manufacturers
3.2.1 Global Anti-Depressant Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Depressant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Depressant Revenue in 2021
3.3 Global Anti-Depressant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Depressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Depressant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Depressant Sales by Type
4.1.1 Global Anti-Depressant Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Depressant Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Depressant Sales Market Share by Type (2017-2028)
4.2 Global Anti-Depressant Revenue by Type
4.2.1 Global Anti-Depressant Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Depressant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Depressant Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Depressant Price by Type
4.3.1 Global Anti-Depressant Price by Type (2017-2022)
4.3.2 Global Anti-Depressant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Depressant Sales by Application
5.1.1 Global Anti-Depressant Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Depressant Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Depressant Sales Market Share by Application (2017-2028)
5.2 Global Anti-Depressant Revenue by Application
5.2.1 Global Anti-Depressant Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Depressant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Depressant Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Depressant Price by Application
5.3.1 Global Anti-Depressant Price by Application (2017-2022)
5.3.2 Global Anti-Depressant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Depressant Market Size by Type
6.1.1 North America Anti-Depressant Sales by Type (2017-2028)
6.1.2 North America Anti-Depressant Revenue by Type (2017-2028)
6.2 North America Anti-Depressant Market Size by Application
6.2.1 North America Anti-Depressant Sales by Application (2017-2028)
6.2.2 North America Anti-Depressant Revenue by Application (2017-2028)
6.3 North America Anti-Depressant Market Size by Country
6.3.1 North America Anti-Depressant Sales by Country (2017-2028)
6.3.2 North America Anti-Depressant Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Depressant Market Size by Type
7.1.1 Europe Anti-Depressant Sales by Type (2017-2028)
7.1.2 Europe Anti-Depressant Revenue by Type (2017-2028)
7.2 Europe Anti-Depressant Market Size by Application
7.2.1 Europe Anti-Depressant Sales by Application (2017-2028)
7.2.2 Europe Anti-Depressant Revenue by Application (2017-2028)
7.3 Europe Anti-Depressant Market Size by Country
7.3.1 Europe Anti-Depressant Sales by Country (2017-2028)
7.3.2 Europe Anti-Depressant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Depressant Market Size by Type
8.1.1 Asia Pacific Anti-Depressant Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Depressant Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Depressant Market Size by Application
8.2.1 Asia Pacific Anti-Depressant Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Depressant Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Depressant Market Size by Region
8.3.1 Asia Pacific Anti-Depressant Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Depressant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Depressant Market Size by Type
9.1.1 Latin America Anti-Depressant Sales by Type (2017-2028)
9.1.2 Latin America Anti-Depressant Revenue by Type (2017-2028)
9.2 Latin America Anti-Depressant Market Size by Application
9.2.1 Latin America Anti-Depressant Sales by Application (2017-2028)
9.2.2 Latin America Anti-Depressant Revenue by Application (2017-2028)
9.3 Latin America Anti-Depressant Market Size by Country
9.3.1 Latin America Anti-Depressant Sales by Country (2017-2028)
9.3.2 Latin America Anti-Depressant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Depressant Market Size by Type
10.1.1 Middle East and Africa Anti-Depressant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Depressant Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Depressant Market Size by Application
10.2.1 Middle East and Africa Anti-Depressant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Depressant Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Depressant Market Size by Country
10.3.1 Middle East and Africa Anti-Depressant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Depressant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Alkermes
11.1.1 Alkermes Corporation Information
11.1.2 Alkermes Overview
11.1.3 Alkermes Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Alkermes Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alkermes Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Corporation Information
11.4.2 Eli Lilly and Company Overview
11.4.3 Eli Lilly and Company Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly and Company Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly and Company Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Lundbeck
11.6.1 Lundbeck Corporation Information
11.6.2 Lundbeck Overview
11.6.3 Lundbeck Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lundbeck Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lundbeck Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Overview
11.7.3 Merck Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merck Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Corporation Information
11.9.2 Teva Pharmaceutical Industries Overview
11.9.3 Teva Pharmaceutical Industries Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Teva Pharmaceutical Industries Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Overview
11.10.3 Takeda Pharmaceutical Anti-Depressant Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Takeda Pharmaceutical Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Takeda Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Depressant Industry Chain Analysis
12.2 Anti-Depressant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Depressant Production Mode & Process
12.4 Anti-Depressant Sales and Marketing
12.4.1 Anti-Depressant Sales Channels
12.4.2 Anti-Depressant Distributors
12.5 Anti-Depressant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Depressant Industry Trends
13.2 Anti-Depressant Market Drivers
13.3 Anti-Depressant Market Challenges
13.4 Anti-Depressant Market Restraints
14 Key Findings in The Global Anti-Depressant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Anti-Depressant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Tricyclic Antidepressants
    Table 3. Major Manufacturers of Selective Serotonin Reuptake Inhibitors
    Table 4. Major Manufacturers of Serotonin-Norepinephrine Reuptake Inhibitors
    Table 5. Major Manufacturers of Monoamine Oxidase Inhibitors
    Table 6. Major Manufacturers of Serotonin Antagonist
    Table 7. Major Manufacturers of Reuptake Inhibitors
    Table 8. Major Manufacturers of Others
    Table 9. Global Anti-Depressant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Anti-Depressant Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Anti-Depressant Sales by Region (2017-2022) & (K Units)
    Table 12. Global Anti-Depressant Sales Market Share by Region (2017-2022)
    Table 13. Global Anti-Depressant Sales by Region (2023-2028) & (K Units)
    Table 14. Global Anti-Depressant Sales Market Share by Region (2023-2028)
    Table 15. Global Anti-Depressant Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Anti-Depressant Revenue Market Share by Region (2017-2022)
    Table 17. Global Anti-Depressant Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Anti-Depressant Revenue Market Share by Region (2023-2028)
    Table 19. Global Anti-Depressant Sales by Manufacturers (2017-2022) & (K Units)
    Table 20. Global Anti-Depressant Sales Share by Manufacturers (2017-2022)
    Table 21. Global Anti-Depressant Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Anti-Depressant Revenue Share by Manufacturers (2017-2022)
    Table 23. Anti-Depressant Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 24. Global Anti-Depressant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Anti-Depressant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Depressant as of 2021)
    Table 26. Anti-Depressant Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Anti-Depressant Product Offered
    Table 28. Date of Manufacturers Enter into Anti-Depressant Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 31. Global Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 32. Global Anti-Depressant Sales Share by Type (2017-2022)
    Table 33. Global Anti-Depressant Sales Share by Type (2023-2028)
    Table 34. Global Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Anti-Depressant Revenue Share by Type (2017-2022)
    Table 37. Global Anti-Depressant Revenue Share by Type (2023-2028)
    Table 38. Anti-Depressant Price by Type (2017-2022) & (USD/Unit)
    Table 39. Global Anti-Depressant Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 40. Global Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 41. Global Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 42. Global Anti-Depressant Sales Share by Application (2017-2022)
    Table 43. Global Anti-Depressant Sales Share by Application (2023-2028)
    Table 44. Global Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Anti-Depressant Revenue Share by Application (2017-2022)
    Table 47. Global Anti-Depressant Revenue Share by Application (2023-2028)
    Table 48. Anti-Depressant Price by Application (2017-2022) & (USD/Unit)
    Table 49. Global Anti-Depressant Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 50. North America Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 51. North America Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 52. North America Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 55. North America Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 56. North America Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Anti-Depressant Sales by Country (2017-2022) & (K Units)
    Table 59. North America Anti-Depressant Sales by Country (2023-2028) & (K Units)
    Table 60. North America Anti-Depressant Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Anti-Depressant Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 63. Europe Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 64. Europe Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 67. Europe Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 68. Europe Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Anti-Depressant Sales by Country (2017-2022) & (K Units)
    Table 71. Europe Anti-Depressant Sales by Country (2023-2028) & (K Units)
    Table 72. Europe Anti-Depressant Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Anti-Depressant Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 75. Asia Pacific Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 76. Asia Pacific Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 79. Asia Pacific Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 80. Asia Pacific Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Anti-Depressant Sales by Region (2017-2022) & (K Units)
    Table 83. Asia Pacific Anti-Depressant Sales by Region (2023-2028) & (K Units)
    Table 84. Asia Pacific Anti-Depressant Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Anti-Depressant Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 87. Latin America Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 88. Latin America Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 91. Latin America Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 92. Latin America Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Anti-Depressant Sales by Country (2017-2022) & (K Units)
    Table 95. Latin America Anti-Depressant Sales by Country (2023-2028) & (K Units)
    Table 96. Latin America Anti-Depressant Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Anti-Depressant Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Anti-Depressant Sales by Type (2017-2022) & (K Units)
    Table 99. Middle East and Africa Anti-Depressant Sales by Type (2023-2028) & (K Units)
    Table 100. Middle East and Africa Anti-Depressant Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Anti-Depressant Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Anti-Depressant Sales by Application (2017-2022) & (K Units)
    Table 103. Middle East and Africa Anti-Depressant Sales by Application (2023-2028) & (K Units)
    Table 104. Middle East and Africa Anti-Depressant Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Anti-Depressant Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Anti-Depressant Sales by Country (2017-2022) & (K Units)
    Table 107. Middle East and Africa Anti-Depressant Sales by Country (2023-2028) & (K Units)
    Table 108. Middle East and Africa Anti-Depressant Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Anti-Depressant Revenue by Country (2023-2028) & (US$ Million)
    Table 110. Alkermes Corporation Information
    Table 111. Alkermes Description and Major Businesses
    Table 112. Alkermes Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Alkermes Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Alkermes Recent Developments
    Table 115. Allergan Corporation Information
    Table 116. Allergan Description and Major Businesses
    Table 117. Allergan Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Allergan Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Allergan Recent Developments
    Table 120. Bristol-Myers Squibb Corporation Information
    Table 121. Bristol-Myers Squibb Description and Major Businesses
    Table 122. Bristol-Myers Squibb Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Bristol-Myers Squibb Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Bristol-Myers Squibb Recent Developments
    Table 125. Eli Lilly and Company Corporation Information
    Table 126. Eli Lilly and Company Description and Major Businesses
    Table 127. Eli Lilly and Company Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Eli Lilly and Company Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Eli Lilly and Company Recent Developments
    Table 130. GlaxoSmithKline Corporation Information
    Table 131. GlaxoSmithKline Description and Major Businesses
    Table 132. GlaxoSmithKline Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. GlaxoSmithKline Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. GlaxoSmithKline Recent Developments
    Table 135. Lundbeck Corporation Information
    Table 136. Lundbeck Description and Major Businesses
    Table 137. Lundbeck Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Lundbeck Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Lundbeck Recent Developments
    Table 140. Merck Corporation Information
    Table 141. Merck Description and Major Businesses
    Table 142. Merck Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Merck Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Merck Recent Developments
    Table 145. Pfizer Corporation Information
    Table 146. Pfizer Description and Major Businesses
    Table 147. Pfizer Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Pfizer Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Pfizer Recent Developments
    Table 150. Teva Pharmaceutical Industries Corporation Information
    Table 151. Teva Pharmaceutical Industries Description and Major Businesses
    Table 152. Teva Pharmaceutical Industries Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Teva Pharmaceutical Industries Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Teva Pharmaceutical Industries Recent Developments
    Table 155. Takeda Pharmaceutical Corporation Information
    Table 156. Takeda Pharmaceutical Description and Major Businesses
    Table 157. Takeda Pharmaceutical Anti-Depressant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Takeda Pharmaceutical Anti-Depressant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Takeda Pharmaceutical Recent Developments
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Anti-Depressant Distributors List
    Table 163. Anti-Depressant Customers List
    Table 164. Anti-Depressant Market Trends
    Table 165. Anti-Depressant Market Drivers
    Table 166. Anti-Depressant Market Challenges
    Table 167. Anti-Depressant Market Restraints
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-Depressant Product Picture
    Figure 3. Global Anti-Depressant Market Share by Type in 2021 & 2028
    Figure 3. Tricyclic Antidepressants Product Picture
    Figure 4. Selective Serotonin Reuptake Inhibitors Product Picture
    Figure 5. Serotonin-Norepinephrine Reuptake Inhibitors Product Picture
    Figure 6. Monoamine Oxidase Inhibitors Product Picture
    Figure 7. Serotonin Antagonist Product Picture
    Figure 8. Reuptake Inhibitors Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Anti-Depressant Market Share by Application in 2021 & 2028
    Figure 11. Major Depressive Disorder
    Figure 12. Obsessive-Compulsive Disorder
    Figure 13. Generalized Anxiety Disorder
    Figure 14. Panic Disorder
    Figure 15. Others
    Figure 16. Anti-Depressant Report Years Considered
    Figure 17. Global Anti-Depressant Sales 2017-2028 (K Units)
    Figure 18. Global Anti-Depressant Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Anti-Depressant Revenue 2017-2028 (US$ Million)
    Figure 20. Global Anti-Depressant Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global Anti-Depressant Sales Market Share by Region (2017-2022)
    Figure 22. Global Anti-Depressant Sales Market Share by Region (2023-2028)
    Figure 23. North America Anti-Depressant Sales YoY (2017-2028) & (K Units)
    Figure 24. North America Anti-Depressant Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Anti-Depressant Sales YoY (2017-2028) & (K Units)
    Figure 26. Europe Anti-Depressant Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Anti-Depressant Sales YoY (2017-2028) & (K Units)
    Figure 28. Asia-Pacific Anti-Depressant Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America Anti-Depressant Sales YoY (2017-2028) & (K Units)
    Figure 30. Latin America Anti-Depressant Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa Anti-Depressant Sales YoY (2017-2028) & (K Units)
    Figure 32. Middle East & Africa Anti-Depressant Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The Anti-Depressant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of Anti-Depressant in the World: Market Share by Anti-Depressant Revenue in 2021
    Figure 35. Global Anti-Depressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 37. Global Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 38. Global Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 39. Global Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 40. North America Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 41. North America Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 42. North America Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 43. North America Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 44. North America Anti-Depressant Sales Share by Country (2017-2028)
    Figure 45. North America Anti-Depressant Revenue Share by Country (2017-2028)
    Figure 46. U.S. Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 49. Europe Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 50. Europe Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 51. Europe Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 52. Europe Anti-Depressant Sales Share by Country (2017-2028)
    Figure 53. Europe Anti-Depressant Revenue Share by Country (2017-2028)
    Figure 54. Germany Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 55. France Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Anti-Depressant Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific Anti-Depressant Revenue Share by Region (2017-2028)
    Figure 65. China Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 68. India Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 70. Taiwan Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 74. Philippines Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Anti-Depressant Sales Share by Country (2017-2028)
    Figure 80. Latin America Anti-Depressant Revenue Share by Country (2017-2028)
    Figure 81. Mexico Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Anti-Depressant Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Anti-Depressant Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Anti-Depressant Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Anti-Depressant Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Anti-Depressant Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Anti-Depressant Revenue Share by Country (2017-2028)
    Figure 90. Turkey Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 92. U.A.E Anti-Depressant Revenue (2017-2028) & (US$ Million)
    Figure 93. Anti-Depressant Value Chain
    Figure 94. Anti-Depressant Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Nebivolol Hydrochloride Market Insights Forecast to 2028
Global Nebivolol Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12T7632
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nefopam Hydrochloride Market Insights Forecast to 2028
Global Nefopam Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-36U7490
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Naratriptan Hydrochloride Market Insights Forecast to 2028
Global Naratriptan Hydrochloride Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-14C7602
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nelfinavir Market Insights Forecast to 2028
Global Nelfinavir Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-25I7469
Fri May 13 00:00:00 UTC 2022

Add to Cart